Back
Open Access

Cardiac resynchroniation therapy for non-LBBB and mid-range QRS: clinical value or questionable benefit?

Session: Cardiac resynchronisation therapy: towards even better outcomes
Topic: Cardiac Resynchronisation Therapy (CRT)
Speaker: Doctor I. Nobrega Fernandes (Vila Real, PT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Isabel Nobrega Fernandes

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)
2 presentations
0 follower

3 more presentations in this session

Risk stratification in patients with cardiac resynchronization therapy: a comparison of EAARN, AAACC, and AL-FINE risk score

Speaker: Doctor I. Martins Moreira (Vila Real, PT)

Access
Abstract
Like
Thumbnail

Broadening the scope of cardiac resynchronization therapy in atrial fibrillation patients

Speaker: Doctor I. Martins Moreira (Vila Real, PT)

Access
Abstract
Like
Thumbnail

Predictors of future need for cardiac resynchronization therapy (CRT) in HFrEF.

Speaker: Doctor P. Van Rijckeghem (Aachen, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Cardiac resynchronisation therapy: towards even better outcomes

Speakers: Doctor I. Nobrega Fernandes, Doctor I. Martins Moreira, Doctor I. Martins Moreira, Doctor P. Van Rijckeghem
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources